Acamprol
Indicated to address alcohol dependence to relieve withdrawal cravings and support long-term abstinence.
- Category
- Addiction Recovery
- Active ingredient
- Acamprosate
- Route
- Oral use
- Form
- Tablet
- Strengths
- 333mg
Prescription and consultation requirements for Acamprol vary by destination and are determined by the fulfilment partner.
Acamprol details
- Condition
- Alcohol Dependence
- Alternative names
- acamprosate
- Therapeutic class
- GABA receptor modulator
- Pharmacological class
- Alcohol Deterrent
- Contraindications
- hypersensitivity to acamprosate; severe renal impairment
- Minor side effects
- diarrhoea; nausea; flatulence
- Moderate side effects
- insomnia; headache; anxiety
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Sun Pharmaceutical Industries Ltd
- Onset Time
- 5–7 days
- Duration
- 12–24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Alcohol
- Age restrictions
- Approved for adults.
Serious side effects
suicidal ideation, requires immediate medical attention; severe depression, requires immediate medical attention
Patient summary
indicated to address alcohol dependence to relieve withdrawal cravings and support long-term abstinence.
Mechanism of action
Restores the normal balance between excitatory glutamatergic and inhibitory GABAergic systems in the central nervous system disrupted by chronic alcohol consumption.
Pregnancy and breastfeeding
TGA Category C: Use only if benefit outweighs fetal risk. Breastfeeding: Caution advised.